Page last updated: 2024-12-07

propylsulfonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

propylsulfonic acid: RN given refers to cpd without locant for propyl moiety [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID78938
CHEMBL ID1741924
SCHEMBL ID5268
MeSH IDM0187454

Synonyms (32)

Synonym
einecs 226-114-2
propanesulphonic acid
nsc 87882
NCI60_041944
NSC87882 ,
nsc-87882
NCGC00013918
propane-1-sulfonic acid
5284-66-2
1-propanesulfonic acid
inchi=1/c3h8o3s/c1-2-3-7(4,5)6/h2-3h2,1h3,(h,4,5,6
NCI87882
NCISTRUC1_001874
NCISTRUC2_000257
NCGC00097027-01
propanesulfonic acid
ammonium propanesulfonate
28553-80-2
propylsulfonic acid
AKOS016009492
CCG-37762
NCGC00013918-02
propane-1-sulphonic acid
KCXFHTAICRTXLI-UHFFFAOYSA-N
SCHEMBL5268
DTXSID0051231
CHEMBL1741924
1-propanesulfonic acid, technical, >=99.0% (t)
FT-0721162
CS-0204485
mfcd00041889
propane-1-sulfonicacid

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" In vivo studies in rats showed that PPS enhanced relative bioavailability of sCT by 45-fold after intestinal administration."( A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
Doshi, N; Gupta, V; Hwang, BH; Mitragotri, S, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (40)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (12.50)18.2507
2000's15 (37.50)29.6817
2010's19 (47.50)24.3611
2020's1 (2.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.31 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index17.79 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (97.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]